基于人类iPSCs的建模揭示了SETBP1作为GATA2缺乏症中染色质重新连接的驱动因素
Joan Pera1,2,3, Damia Romero-Moya1,2, Eric Torralba-Sales1,2
1Hematopoietic Stem Cell Biology and Leukemogenesis, Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain.
Nature communications
|November 17, 2025
概括
缺乏GATA2的患者容易患上髓状腺癌. 同时发生的SETBP1或ASXL1突变会损害骨髓分化,所有三种突变都严重削弱了新iPSC模型中的祖先.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 干细胞生物学 干细胞生物学
背景情况:
- 缺少GATA2会使个体易患髓囊炎性瘤 (MDS) 和急性髓质白血病 (AML).
- 在GATA2相关的MDS中经常发现SETBP1和ASXL1基因突变,但它们的功能作用尚不清楚.
- 了解这些突变对于破译MDS病原体和开发疗法至关重要.
研究的目的:
- 用人类诱导多能干细胞 (hiPSC) 模型研究SETBP1和ASXL1突变对GATA2缺乏症的影响.
- 通过精确的基因组编辑,重建与GATA2相关的MDS中观察到的逐步突变轨迹.
- 为了阐明GATA2,SETBP1和ASXL1突变在骨髓发育中的协同作用.
主要方法:
- 开发一个基于hiPSC的系统来建模GATA2缺陷.
- 利用精确的基因组编辑引入SETBP1和ASXL1突变到GATA2缺陷的hiPSC中.
- 分析逐步突变对造血原体分化和染色质可访问性的影响.
主要成果:
- 仅仅GATA2突变对造血原始体的影响很小.
- 同时发生的SETBP1或ASXL1突变与GATA2缺陷损害了髓状细胞分化.
- GATA2,SETBP1和ASXL1突变的组合严重耗尽了髓状细胞原始体,模仿了与GATA2相关的MDS.
- SETBP1突变在保持染色质可访问性方面发挥了主导作用,而不管ASXL1共突变.
结论:
- 开发的hiPSC模型准确地概括了与GATA2相关的MDS的关键特征.
- SETBP1和ASXL1突变与GATA2缺陷协同相互作用,驱动骨髓状细胞疾病的进展.
- 这项研究提供了对GATA2缺乏症中MDS背后的分子机制的关键见解,并为治疗开发提供了一个平台.
相关概念视频
01:32Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
01:21EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
01:29Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
03:17Inheritance of Chromatin Structures
7.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.2K